Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of SINERGIAPS, an Intervention to Improve Patient Safety in Primary Care Centers in Spain Based on Patients' Perceptions and Experiences. Hybrid Type I Clinical Trial

NCT05958108 is registered in ClinicalTrials.gov with Fundació d'investigació Sanitària de les Illes Balears as lead sponsor.

NCT NCT05958108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05958108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of SINERGIAPS, an Intervention to Improve Patient Safety in Primary Care Centers in Spain Based on Patients' Perceptions and Experiences. Hybrid Type I Clinical Trial
Lead sponsor
Fundació d'investigació Sanitària de les Illes Balears
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
June 30, 2026
Enrollment
110 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

patient safety